Tech Company Financing Transactions
QureBio Funding Round
QureBio, based in Shanghai, scored $14 million from EFung Capital and private investors.
Transaction Overview
Company Name
Announced On
6/5/2025
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Series C
Investors
EFung Capital (Lead Investor)
Proceeds Purpose
The company intends to use the funds to accelerate its clinical trials and advance its pipeline of new antibody therapeutics.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
second floor of the Incubation Building, No. 1227, Zhangheng 204, 206, 207
Shanghai, Undisclosed
China
Shanghai, Undisclosed
China
Phone
Website
Email Address
Not Recorded
Overview
Qure Bio, established in 2017, is an innovative drug discovery and development company focusing on biological drugs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Xiangdong Qu
Browse more venture capital transactions:
Prev: 6/5/2025: Cosm Medical venture capital transaction
Next: 6/5/2025: Thread AI venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record tech company VC transactions. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs